Asthma Society of Ireland’s Post

Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, a new Cochrane review has found. Researchers from Evidence Synthesis Ireland and Cochrane Ireland (University of Galway), and the European Centre for Disease Prevention and Control (ECDC) analyzed 14 clinical trials involving more than 100,000 participants. The findings show strong evidence that RSV vaccines can protect the most vulnerable – infants and older adults – helping reduce hospitalizations and pressure on health systems. Learn more in our feature: https://lnkd.in/d5Kh53wY #RSV #Vaccines #PublicHealth #Evidence #SystematicReviews

Respiratory tract infections increase during the autumn and winter months. These infections can lead to serious health problems, especially for the elderly, pregnant women, people with chronic diseases, and those with weakened immune systems. Vaccination is critically important during this season to reduce the risk of hospitalization and complications. Dr. İrem Altunoluk, Specialist Physician and Responsible Doctor of Güven Hospital’s Adult Vaccination Polyclinic, explains the key points about vaccination against respiratory pathogens: 📌 Why is the flu more than just a “cold,” and what benefits does the flu vaccine provide? 📌 Who is more likely to experience severe RSV infection, and who is the vaccine recommended for? 📌 What diseases does the pneumococcus bacteria cause, and who should get the pneumococcal vaccine? Watch our video for detailed information. 🎥👇 #FluVaccine #RespiratoryInfection #GüvenleSağlık

As we head into the 2025-2026 respiratory virus season, there are several key changes to vaccine codes. Below are the major vaccine code‐set updates for influenza, COVID-19, RSV, and related respiratory vaccines. Take time to review and ensure your systems and practices are aligned to avoid miscoding, claim denials, or reporting delays. Flu vaccine codes: https://lnkd.in/g3T_Xejm Other respiratory vaccine codes: https://lnkd.in/gVNkGyam

A US Centers for Disease Control vaccines advisory panel has voted to recommend separate vaccines for measles, mumps, rubella and chickenpox instead of a single combined jab. 🔗 Full story: https://buff.ly/gMqofZb #PublicHealth #VaccinePolicy #USA #Research #HealthTech

The newly opened Greater Manchester Commercial Research Delivery Centre (GM CRDC) has begun its first set of studies, aiming to evaluate the effectiveness of vaccines for severe acute respiratory infections. Supported by the National Institute for Health and Care Research, the three studies are seeking to recruit 300 participants in total, all patients that were hospitalised last winter with severe acute respiratory infections. The research will provide crucial real-world evaluation of vaccine performance, assessing how vaccines for diseases like COVID-19 and RSV perform across diverse populations and outside of controlled clinical testing environments. It is hoped that data from these studies will help to inform future vaccination programmes, ensuring that each is designed to deliver the maximum benefit and protection. Read more in PharmaTimes Media Ltd: https://bit.ly/46D7399

Robert Goldman MD, DO, PhD Worldhealth.net New research reveals four distinct COVID-19 vaccine response patterns. Those with strong initial immunity but rapid antibody decline, “rapid-decliners”, face higher infection risk. Tracking antibody changes over time may guide personalized booster strategies. #worldhealth #publichealth #COVID19 #immunology #precisionmedicine #medicine #regenerativemedicine #clinicalresearch #antiaging #health #wellness https://lnkd.in/gPRHt6r4

Robert Goldman MD, DO, PhD Worldhealth.net New research reveals four distinct COVID-19 vaccine response patterns. Those with strong initial immunity but rapid antibody decline, “rapid-decliners”, face higher infection risk. Tracking antibody changes over time may guide personalized booster strategies. #worldhealth #publichealth #COVID19 #immunology #precisionmedicine #medicine #regenerativemedicine #clinicalresearch #antiaging #health #wellness https://lnkd.in/gVsbqXMm

Primary care providers: Protect seniors, empower choices through comprehensive RSV prevention resources for your older patients. 🚩 Protect your high-risk patients: New research confirms the severity of RSV in older adults with cardiovascular disease and immunocompromised conditions. 🚩 Reduce hospitalization risk: Effective RSV vaccines are now available, offering significant protection against RSV-associated respiratory illness, especially for the most vulnerable populations. 🚩 Empower informed decisions: Access comprehensive patient education materials and data to facilitate discussion about RSV vaccination. 🚩 Invest in their well-being: By prioritizing RSV vaccination, you can help your patients maintain their independence and quality of life. View the Cleveland Clinic educational resource on RSV and vaccine hesitancy for providers via the link in the comments. #CME #RSV #vaccinehesitancy #primarycare

For older adults, the flu isn’t just an inconvenience — it can be serious, even life-threatening. Seniors over 65 account for the majority of flu-related hospitalizations each year because their immune systems naturally weaken with age. Families can play a key role in prevention and protection during flu season. ✨ Here’s what you should know: 🦠 Higher risk of complications – Seniors are more vulnerable to pneumonia, dehydration, and worsening of chronic conditions like asthma, COPD, or heart disease. 💉 Vaccines matter – Annual flu shots (and pneumonia vaccines, if recommended) are the most effective protection. High-dose flu vaccines are often suggested for adults 65+. 🧼 Prevention at home – Frequent handwashing, disinfecting commonly touched surfaces, and limiting contact with sick visitors all help reduce risk. 🥗 Immune support – A balanced diet, proper hydration, and regular rest strengthen the body’s ability to fight infection. 👨👩👧 Family responsibility – Caregivers and family members should also stay current with flu shots to protect vulnerable loved ones. 💙 Flu season prep isn’t just about staying healthy — it’s about reducing stress for families and giving seniors the best chance to enjoy the season safely. 👉 For more guidance and personalized support, visit: https://lnkd.in/eEBieEBD

📢 Needle-free influenza protection for WA kids: FluMist nasal spray coming in 2026 👃 WA children aged 2 to under 12 years can get a needle-free influenza vaccine before the 2026 influenza season. The new FluMist intranasal vaccine works as a gentle nasal spray into both nostrils. It protects children from influenza without using a needle. This initiative will deliver 130,000 free doses to eligible children across WA, like 10-year-old Elsie. Elsie and her mum, sat down with Paediatric Infectious Diseases Physician at Perth Children's Hospital, Prof Chris Blyth, to learn how FluMist will make influenza protection easier and less stressful for kids. Why it matters: 💪 Helps protect children from serious influenza related illness 🧠 Reduces needle anxiety 📈 Expected to boost vaccine uptake This is a big step forward in making immunisation more accessible for people in WA. Read more 👉 https://lnkd.in/gJwbVhuM Shirley Bowen, Christopher Blyth, Child and Adolescent Health Service #PublicHealth #Immunisation #FluMist #WAHealth #HealthyWA #ChildHealth #NeedleFree #InfluenzaVaccine #HealthInnovation